Skip to main content
Top
Published in: Journal of Endocrinological Investigation 1/2024

Open Access 04-06-2023 | Osteogenesis Imperfecta | Original Article

Genotype–phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta

Authors: X. Lin, J. Hu, B. Zhou, Q. Zhang, Y. Jiang, O. Wang, W. Xia, X. Xing, M. Li

Published in: Journal of Endocrinological Investigation | Issue 1/2024

Login to get access

Abstract

Purpose

To evaluate the genotypic and phenotypic relationship in a large cohort of OI patients and to compare the differences between eastern and western OI cohorts.

Methods

A total of 671 OI patients were included. Pathogenic mutations were identified, phenotypic information was collected, and relationships between genotypes and phenotypes were analyzed. Literature about western OI cohorts was searched, and differences were compared between eastern and western OI cohorts.

Results

A total of 560 OI patients were identified as carrying OI pathogenic mutations, and the positive detection rate of disease-causing gene mutations was 83.5%. Mutations in 15 OI candidate genes were identified, with COL1A1 (n = 308, 55%) and COL1A2 (n = 164, 29%) being the most common mutations, and SERPINF1 and WNT1 being the most common biallelic variants. Of the 414 probands, 48.8, 16.9, 29.2 and 5.1% had OI types I, III, IV and V, respectively. Peripheral fracture was the most common phenotype (96.6%), and femurs (34.7%) were most commonly affected. Vertebral compression fracture was observed in 43.5% of OI patients. Biallelic or COL1A2 mutation led to more bone deformities and poorer mobility than COL1A1 mutation (all P < 0.05). Glycine substitution of COL1A1 or COL1A2 or biallelic variants led to more severe phenotypes than haploinsufficiency of collagen type I α chains, which induced the mildest phenotypes. Although the gene mutation spectrum varied among countries, the fracture incidence was similar between eastern and western OI cohorts.

Conclusion

The findings are valuable for accurate diagnosis and treatment of OI, mechanism exploration and prognosis judgment. Genetic profiles of OI may vary among races, but the mechanism needs to be explored.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jovanovic M, Guterman-Ram G, Marini JC (2022) Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev 43:61–90PubMedCrossRef Jovanovic M, Guterman-Ram G, Marini JC (2022) Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types. Endocr Rev 43:61–90PubMedCrossRef
2.
go back to reference Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052PubMedCrossRef Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052PubMedCrossRef
3.
go back to reference Chetty M, Roomaney IA, Beighton P (2021) The evolution of the nosology of osteogenesis imperfecta. Clin Genet 99:42–52PubMedCrossRef Chetty M, Roomaney IA, Beighton P (2021) The evolution of the nosology of osteogenesis imperfecta. Clin Genet 99:42–52PubMedCrossRef
6.
go back to reference Erbaş İM, İlgün Gürel D, Manav Kabayeğit Z, Koç A, Ünüvar T, Abacı A et al (2022) Clinical, genetic characteristics and treatment outcomes of children and adolescents with osteogenesis imperfecta: a two-center experience. Connect Tissue Res 63:349–358PubMedCrossRef Erbaş İM, İlgün Gürel D, Manav Kabayeğit Z, Koç A, Ünüvar T, Abacı A et al (2022) Clinical, genetic characteristics and treatment outcomes of children and adolescents with osteogenesis imperfecta: a two-center experience. Connect Tissue Res 63:349–358PubMedCrossRef
7.
go back to reference China. 2021 BoSotPsRo. China Statistical Yearbook-2021. China Statistics Press, Beijing. China. 2021 BoSotPsRo. China Statistical Yearbook-2021. China Statistics Press, Beijing.
8.
go back to reference Wei S, Yao Y, Shu M, Gao L, Zhao J, Li T et al (2022) Genotype-phenotype relationship and follow-up analysis of a chinese cohort with osteogenesis imperfecta. Endocr Pract 28:760–766PubMedCrossRef Wei S, Yao Y, Shu M, Gao L, Zhao J, Li T et al (2022) Genotype-phenotype relationship and follow-up analysis of a chinese cohort with osteogenesis imperfecta. Endocr Pract 28:760–766PubMedCrossRef
9.
go back to reference Xi L, Zhang H, Zhang ZL (2021) Clinical and genetic analysis in 185 Chinese probands of osteogenesis imperfecta. J Bone Miner Metab 39:416–422PubMedCrossRef Xi L, Zhang H, Zhang ZL (2021) Clinical and genetic analysis in 185 Chinese probands of osteogenesis imperfecta. J Bone Miner Metab 39:416–422PubMedCrossRef
10.
go back to reference Chen P, Tan Z, Shek HT, Zhang JN, Zhou Y, Yin S et al (2022) Phenotypic spectrum and molecular basis in a chinese cohort of osteogenesis imperfecta with mutations in type i collagen. Front Genet 13:816078PubMedPubMedCentralCrossRef Chen P, Tan Z, Shek HT, Zhang JN, Zhou Y, Yin S et al (2022) Phenotypic spectrum and molecular basis in a chinese cohort of osteogenesis imperfecta with mutations in type i collagen. Front Genet 13:816078PubMedPubMedCentralCrossRef
11.
go back to reference Li L, Mao B, Li S, Xiao J, Wang H, Zhang J et al (2019) Genotypic and phenotypic characterization of Chinese patients with osteogenesis imperfecta. Hum Mutat 40:588–600PubMed Li L, Mao B, Li S, Xiao J, Wang H, Zhang J et al (2019) Genotypic and phenotypic characterization of Chinese patients with osteogenesis imperfecta. Hum Mutat 40:588–600PubMed
12.
go back to reference Li H, Ji CY, Zong XN (2009) Zhang YQ [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi 47:487–492PubMed Li H, Ji CY, Zong XN (2009) Zhang YQ [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi 47:487–492PubMed
13.
go back to reference Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ (2011) Normative data and percentile curves for Dual Energy X-ray Absorptiometry in healthy Indian girls and boys aged 5–17 years. Bone 48:810–819PubMedCrossRef Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ (2011) Normative data and percentile curves for Dual Energy X-ray Absorptiometry in healthy Indian girls and boys aged 5–17 years. Bone 48:810–819PubMedCrossRef
14.
go back to reference Xu H, Zhao Z, Wang H, Ding M, Zhou A, Wang X et al (2013) Bone mineral density of the spine in 11,898 Chinese infants and young children: a cross-sectional study. PLoS ONE 8:e82098PubMedPubMedCentralCrossRef Xu H, Zhao Z, Wang H, Ding M, Zhou A, Wang X et al (2013) Bone mineral density of the spine in 11,898 Chinese infants and young children: a cross-sectional study. PLoS ONE 8:e82098PubMedPubMedCentralCrossRef
15.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
16.
go back to reference Kuznia AL, Hernandez AK, Lee LU (2020) Adolescent idiopathic scoliosis: common questions and answers. Am Fam Physician 101:19–23PubMed Kuznia AL, Hernandez AK, Lee LU (2020) Adolescent idiopathic scoliosis: common questions and answers. Am Fam Physician 101:19–23PubMed
17.
go back to reference Liu Y, Asan MD, Lv F, Xu X, Wang J et al (2017) Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 28:2985–2995PubMedCrossRef Liu Y, Asan MD, Lv F, Xu X, Wang J et al (2017) Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 28:2985–2995PubMedCrossRef
18.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405–424PubMedPubMedCentralCrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405–424PubMedPubMedCentralCrossRef
19.
go back to reference Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC et al (2022) Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech 15:5CrossRef Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC et al (2022) Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech 15:5CrossRef
20.
go back to reference Tüysüz B, Elkanova L, Uludağ Alkaya D, Güleç Ç, Toksoy G, Güneş N et al (2022) Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. Bone 155:116293PubMedCrossRef Tüysüz B, Elkanova L, Uludağ Alkaya D, Güleç Ç, Toksoy G, Güneş N et al (2022) Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. Bone 155:116293PubMedCrossRef
21.
go back to reference Bardai G, Moffatt P, Glorieux FH, Rauch F (2016) DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int 27:3607–3613PubMedCrossRef Bardai G, Moffatt P, Glorieux FH, Rauch F (2016) DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int 27:3607–3613PubMedCrossRef
22.
go back to reference Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, Pedrini E et al (2019) Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet 27:1090–1100PubMedPubMedCentralCrossRef Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, Pedrini E et al (2019) Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet 27:1090–1100PubMedPubMedCentralCrossRef
23.
go back to reference Patel RM, Nagamani SC, Cuthbertson D, Campeau PM, Krischer JP, Shapiro JR et al (2015) A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers. Clin Genet 87:133–140PubMedCrossRef Patel RM, Nagamani SC, Cuthbertson D, Campeau PM, Krischer JP, Shapiro JR et al (2015) A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers. Clin Genet 87:133–140PubMedCrossRef
24.
go back to reference Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö et al (2015) Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet 23:1042–1050PubMedPubMedCentralCrossRef Lindahl K, Åström E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren Ö et al (2015) Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet 23:1042–1050PubMedPubMedCentralCrossRef
26.
go back to reference Qiang S, Lu C, Xu F (2022) Disrupting effects of osteogenesis imperfecta mutations could be predicted by local hydrogen bonding energy. Biomolecules 12:1140CrossRef Qiang S, Lu C, Xu F (2022) Disrupting effects of osteogenesis imperfecta mutations could be predicted by local hydrogen bonding energy. Biomolecules 12:1140CrossRef
28.
go back to reference Zerfu T, Yong B, Harrington J, Howard A (2022) Does the skeletal phenotype of osteogenesis imperfecta differ for patients with non-COL1A1/2 mutations? a retrospective study in 113 patients. J Pediatr Orthop 42:e507–e514PubMedCrossRef Zerfu T, Yong B, Harrington J, Howard A (2022) Does the skeletal phenotype of osteogenesis imperfecta differ for patients with non-COL1A1/2 mutations? a retrospective study in 113 patients. J Pediatr Orthop 42:e507–e514PubMedCrossRef
29.
go back to reference Pepin MG, Byers PH (2015) What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases. Am J Med Genet C Semin Med Genet 169:307–313PubMedCrossRef Pepin MG, Byers PH (2015) What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases. Am J Med Genet C Semin Med Genet 169:307–313PubMedCrossRef
30.
go back to reference Edouard T, Glorieux FH, Rauch F (2011) Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study. J Bone Miner Res 26:2245–2251PubMedCrossRef Edouard T, Glorieux FH, Rauch F (2011) Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study. J Bone Miner Res 26:2245–2251PubMedCrossRef
31.
go back to reference Edouard T, Glorieux FH, Rauch F (2011) Predictors and correlates of vitamin d status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab 96:3193–3198PubMedCrossRef Edouard T, Glorieux FH, Rauch F (2011) Predictors and correlates of vitamin d status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab 96:3193–3198PubMedCrossRef
32.
go back to reference Wilsford LD, Sullivan E, Mazur LJ (2013) Risk factors for vitamin D deficiency in children with osteogenesis imperfecta. J Pediatr Orthop 33:575–579PubMedCrossRef Wilsford LD, Sullivan E, Mazur LJ (2013) Risk factors for vitamin D deficiency in children with osteogenesis imperfecta. J Pediatr Orthop 33:575–579PubMedCrossRef
33.
go back to reference de Jongh RT, van Schoor NM, Lips P (2017) Changes in vitamin D endocrinology during aging in adults. Mol Cell Endocrinol 453:144–150PubMedCrossRef de Jongh RT, van Schoor NM, Lips P (2017) Changes in vitamin D endocrinology during aging in adults. Mol Cell Endocrinol 453:144–150PubMedCrossRef
34.
go back to reference Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367–1374PubMedCrossRef Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367–1374PubMedCrossRef
35.
go back to reference Li S, Cao Y, Wang H, Li L, Ren X, Mi H et al (2020) Genotypic and phenotypic analysis in chinese cohort with autosomal recessive osteogenesis imperfecta. Front Genet 11:984PubMedPubMedCentralCrossRef Li S, Cao Y, Wang H, Li L, Ren X, Mi H et al (2020) Genotypic and phenotypic analysis in chinese cohort with autosomal recessive osteogenesis imperfecta. Front Genet 11:984PubMedPubMedCentralCrossRef
36.
go back to reference Thornley P, Bishop N, Baker D, Brock J, Arundel P, Burren C et al (2022) Non-collagen pathogenic variants resulting in the osteogenesis imperfecta phenotype in children: a single-country observational cohort study. Arch Dis Child 107:486–490PubMedCrossRef Thornley P, Bishop N, Baker D, Brock J, Arundel P, Burren C et al (2022) Non-collagen pathogenic variants resulting in the osteogenesis imperfecta phenotype in children: a single-country observational cohort study. Arch Dis Child 107:486–490PubMedCrossRef
37.
go back to reference Holtz AP, Souza LT, Ribeiro EM, Acosta AX, Lago R, Simoni G et al (2023) Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort. Bone 169:116683PubMedCrossRef Holtz AP, Souza LT, Ribeiro EM, Acosta AX, Lago R, Simoni G et al (2023) Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort. Bone 169:116683PubMedCrossRef
38.
go back to reference Sun L, Hu J, Liu J, Zhang Q, Wang O, Jiang Y et al (2022) Relationship of pathogenic mutations and responses to zoledronic acid in a cohort of osteogenesis imperfecta children. J Clin Endocrinol Metab 107:2571–2579PubMedCrossRef Sun L, Hu J, Liu J, Zhang Q, Wang O, Jiang Y et al (2022) Relationship of pathogenic mutations and responses to zoledronic acid in a cohort of osteogenesis imperfecta children. J Clin Endocrinol Metab 107:2571–2579PubMedCrossRef
39.
go back to reference Schindeler A, Lee LR, O’Donohue AK, Ginn SL, Munns CF (2022) Curative cell and gene therapy for osteogenesis imperfecta. J Bone Miner Res 37:826–836PubMedCrossRef Schindeler A, Lee LR, O’Donohue AK, Ginn SL, Munns CF (2022) Curative cell and gene therapy for osteogenesis imperfecta. J Bone Miner Res 37:826–836PubMedCrossRef
40.
go back to reference Nisar H, Wajid B, Shahid S, Anwar F, Wajid I, Khatoon A et al (2021) Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases. Exp Biol Med (Maywood) 246:2610–2617PubMedCrossRef Nisar H, Wajid B, Shahid S, Anwar F, Wajid I, Khatoon A et al (2021) Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseases. Exp Biol Med (Maywood) 246:2610–2617PubMedCrossRef
41.
go back to reference McInerney-Leo AM, Duncan EL (2020) Massively parallel sequencing for rare genetic disorders: potential and pitfalls. Front Endocrinol (Lausanne) 11:628946PubMedCrossRef McInerney-Leo AM, Duncan EL (2020) Massively parallel sequencing for rare genetic disorders: potential and pitfalls. Front Endocrinol (Lausanne) 11:628946PubMedCrossRef
42.
go back to reference Chen Y, Yang S, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H et al (2021) Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta. Nat Commun 12:7199PubMedPubMedCentralCrossRef Chen Y, Yang S, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H et al (2021) Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta. Nat Commun 12:7199PubMedPubMedCentralCrossRef
43.
go back to reference Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L et al (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212–220PubMedCrossRef Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L et al (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212–220PubMedCrossRef
Metadata
Title
Genotype–phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta
Authors
X. Lin
J. Hu
B. Zhou
Q. Zhang
Y. Jiang
O. Wang
W. Xia
X. Xing
M. Li
Publication date
04-06-2023
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2024
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02123-2

Other articles of this Issue 1/2024

Journal of Endocrinological Investigation 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine